- November 17, 2017
- Taiho Pharmaceutical Co., Ltd.
Taiho Pharmaceutical Head Office to Temporarily Relocate
Taiho Pharmaceutical Co., Ltd. announced today that its Head Office will be temporarily relocated due to the reconstruction of its current building. The new location will be open for business starting on November 27, 2017. See below for further details.
| New temporary address | 2F-9F, PMO Uchikanda Building, 1-14-10 Uchikanda, Chiyoda-ku, Tokyo 101-0047 Japan |
|---|---|
| Telephone | +81-3−3294−4527 * The telephone number will not be changed. |
| Relocated organization | divisions in the Head Office * The Headquarters Annex (at 1-2-4 Uchikanda, Chiyoda-ku) will not be relocated during this time. |
The new head office building is scheduled for completion in the summer of 2020. The address for the head office and principal office for manufacturing and sales divisions listed in registration will not be affected by the relocation or reconstruction.
Otemachi Station：Approx. 7-minute walk from C1 Exit
JR Kanda Station：Approx. 7-minute walk from North Exit
Ogawamachi and Awajicho Station：Approx. 4-minute walk from B6 Exit
Information in this news release was current as of the original release date.
Taiho Pharmaceutical's news releases are intended to provide information to the media. It may contain information about ethical drugs or products under development, however information contained in the news releases are not intended to constitute promotion, advertisement, or medical advice.